Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen M J Douglas

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Expert Reviews in Molecular Medicine|May 7, 2005
Inflammation and atherosclerosis in rheumatoid arthritisRobert J Stevens, Karen M J Douglas, Athanasios N Saratzis, et al.
Rheumatology International|April 3, 2012
Lack of association between polymorphisms of thrombogenic genes and disease susceptibility in rheumatoid arthritisTheodoros Dimitroulas, Karen M J Douglas, Jacqueline Smith, et al.
Arthritis Research & Therapy|July 18, 2009
Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional studyTracey E Toms, Vasileios F Panoulas, Holly John, et al.
Rheumatology International|April 15, 2010
Platelet function in rheumatoid arthritis: arthritic and cardiovascular implicationsArmen Yuri Gasparyan, Antonios Stavropoulos-Kalinoglou, Dimitri P Mikhailidis, et al.
Inflammation & Allergy Drug Targets|November 13, 2009
Association of mean platelet volume with hypertension in rheumatoid arthritisArmen Yuri Gasparyan, Antonios Stavropoulos-Kalinoglou, Tracey E Toms, et al.
Arthritis Research & Therapy|December 19, 2008
Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional studyTracey E Toms, Vasileios F Panoulas, Karen M J Douglas, et al.
Musculoskeletal Care|April 26, 2007
Prevalence and predictors of ocular manifestations of RA: is there a need for routine screening?Holly Piper, Karen M J Douglas, Gareth J Treharne, et al.
The Journal of Rheumatology|December 17, 2011
Apolipoprotein E gene polymorphisms are strong predictors of inflammation and dyslipidemia in rheumatoid arthritisTracey E Toms, Jacqueline P Smith, Vasileios F Panoulas, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 9, 2009
Lack of an association of GNB3 C825T polymorphism and blood pressure in patients with rheumatoid arthritisVasileios F Panoulas, Jacqueline P Smith, Antonios Stavropoulos-Kalinoglou, et al.
Current Vascular Pharmacology|September 18, 2009
The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseasesArmen Yuri Gasparyan, Antonios Stavropoulos-Kalinoglou, Dimitri P Mikhailidis, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Expert Reviews in Molecular Medicine|May 7, 2005
Inflammation and atherosclerosis in rheumatoid arthritisRobert J Stevens, Karen M J Douglas, Athanasios N Saratzis, et al.
Rheumatology International|April 3, 2012
Lack of association between polymorphisms of thrombogenic genes and disease susceptibility in rheumatoid arthritisTheodoros Dimitroulas, Karen M J Douglas, Jacqueline Smith, et al.
Arthritis Research & Therapy|July 18, 2009
Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional studyTracey E Toms, Vasileios F Panoulas, Holly John, et al.
Rheumatology International|April 15, 2010
Platelet function in rheumatoid arthritis: arthritic and cardiovascular implicationsArmen Yuri Gasparyan, Antonios Stavropoulos-Kalinoglou, Dimitri P Mikhailidis, et al.
Inflammation & Allergy Drug Targets|November 13, 2009
Association of mean platelet volume with hypertension in rheumatoid arthritisArmen Yuri Gasparyan, Antonios Stavropoulos-Kalinoglou, Tracey E Toms, et al.
Arthritis Research & Therapy|December 19, 2008
Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional studyTracey E Toms, Vasileios F Panoulas, Karen M J Douglas, et al.
Musculoskeletal Care|April 26, 2007
Prevalence and predictors of ocular manifestations of RA: is there a need for routine screening?Holly Piper, Karen M J Douglas, Gareth J Treharne, et al.
The Journal of Rheumatology|December 17, 2011
Apolipoprotein E gene polymorphisms are strong predictors of inflammation and dyslipidemia in rheumatoid arthritisTracey E Toms, Jacqueline P Smith, Vasileios F Panoulas, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 9, 2009
Lack of an association of GNB3 C825T polymorphism and blood pressure in patients with rheumatoid arthritisVasileios F Panoulas, Jacqueline P Smith, Antonios Stavropoulos-Kalinoglou, et al.
Current Vascular Pharmacology|September 18, 2009
The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseasesArmen Yuri Gasparyan, Antonios Stavropoulos-Kalinoglou, Dimitri P Mikhailidis, et al.
Pageof 3